263 related articles for article (PubMed ID: 29250900)
1. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions.
Peng HP; Peng JH
J Cosmet Dermatol; 2018 Feb; 17(1):33-38. PubMed ID: 29250900
[TBL] [Abstract][Full Text] [Related]
2. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
Yeh YT; Peng JH; Peng HP
J Cosmet Dermatol; 2018 Oct; 17(5):675-687. PubMed ID: 30091170
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for the treatment of hypertrophy of the masseter muscle.
Kim NH; Park RH; Park JB
Plast Reconstr Surg; 2010 Jun; 125(6):1693-1705. PubMed ID: 20517093
[TBL] [Abstract][Full Text] [Related]
4. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
[TBL] [Abstract][Full Text] [Related]
5. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
Shome D; Khare S; Kapoor R
Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
[TBL] [Abstract][Full Text] [Related]
7. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness?
Park G; Choi YC; Bae JH; Kim ST
Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291
[TBL] [Abstract][Full Text] [Related]
8. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A treatment for contouring of the lower face.
Park MY; Ahn KY; Jung DS
Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical masseteric bulging after botulinum neurotoxin type A injection.
Sandhu S; Shaefer J
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514
[TBL] [Abstract][Full Text] [Related]
11. Botulinum Toxin Injections for Masseter Reduction in East Asians.
Cheng J; Hsu SH; McGee JS
Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for masseter reduction in Asian patients.
Ahn J; Horn C; Blitzer A
Arch Facial Plast Surg; 2004; 6(3):188-91. PubMed ID: 15148129
[TBL] [Abstract][Full Text] [Related]
13. [The use of botulinum toxin type A in masseter muscle hypertrophy: long-term effects and lasting improvement].
Aydil B; Başaran B; Unsaler S; Süoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):249-53. PubMed ID: 22991984
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
Kwon JS; Kim ST; Jeon YM; Choi JH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
[TBL] [Abstract][Full Text] [Related]
15. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment.
von Lindern JJ; Niederhagen B; Appel T; Bergé S; Reich RH
Plast Reconstr Surg; 2001 Feb; 107(2):327-32. PubMed ID: 11214045
[TBL] [Abstract][Full Text] [Related]
16. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
Almukhtar RM; Fabi SG
Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical bulging of muscle after injection of botulinum neurotoxin type A into hypertrophied masseter muscle.
Lee SJ; Kang JM; Kim YK; Park J; Kim DY
J Dermatol; 2012 Sep; 39(9):804-5. PubMed ID: 22413811
[No Abstract] [Full Text] [Related]
19. A Cadaveric Study of Dye Spreading: Determining the Ideal Injection Pattern for Masseter Hypertrophy.
Sermswan P; Tansatit T; Meevassana J; Panchaprateep R
Dermatol Surg; 2021 Oct; 47(10):1354-1358. PubMed ID: 34417381
[TBL] [Abstract][Full Text] [Related]
20. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
Lee JS; Son HS; Kim BJ; Lee YW
Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
